105 related articles for article (PubMed ID: 29045069)
1. Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.
Ainsworth HC; Marion MC; Bertero T; Brucato A; Cimaz R; Costedoat-Chalumeau N; Fredi M; Gaffney P; Kelly J; Levesque K; Maltret A; Morel N; Ramoni V; Ruffatti A; Langefeld CD; Buyon JP; Clancy RM
Arthritis Rheumatol; 2017 Nov; 69(11):2170-2174. PubMed ID: 29045069
[TBL] [Abstract][Full Text] [Related]
2. The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence.
Meisgen S; Östberg T; Salomonsson S; Ding B; Eliasson H; Mälarstig A; Alfredsson L; Klareskog L; Hamsten A; Olsson T; Axelsson T; ; Gadler F; Jonzon A; Sonesson SE; Kockum I; Wahren-Herlenius M
J Intern Med; 2014 Jun; 275(6):640-51. PubMed ID: 24354957
[TBL] [Abstract][Full Text] [Related]
3. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.
Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A
Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero.
Mofors J; Eliasson H; Ambrosi A; Salomonsson S; Skog A; Fored M; Ekbom A; Bergman G; Sonesson SE; Wahren-Herlenius M
Ann Rheum Dis; 2019 May; 78(5):696-703. PubMed ID: 30808622
[TBL] [Abstract][Full Text] [Related]
5. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block.
Clancy RM; Backer CB; Yin X; Kapur RP; Molad Y; Buyon JP
J Immunol; 2003 Sep; 171(6):3253-61. PubMed ID: 12960355
[TBL] [Abstract][Full Text] [Related]
6. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
[TBL] [Abstract][Full Text] [Related]
7. Reactivity to the p305 Epitope of the α1G T-Type Calcium Channel and Autoimmune-Associated Congenital Heart Block.
Markham AJ; Rasmussen SE; Salmon JE; Martinez-Ortiz W; Cardozo TJ; Clancy RM; Buyon JP
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25994441
[TBL] [Abstract][Full Text] [Related]
8. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
[TBL] [Abstract][Full Text] [Related]
9. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block.
Ivanchenko M; Thorlacius GE; Hedlund M; Ottosson V; Meneghel L; Björkander S; Ossoinak A; Tingström J; Bremme K; Sverremark-Ekström E; Gemzell-Danielsson K; Sonesson SE; Chemin K; Wahren-Herlenius M
Ann Rheum Dis; 2021 Feb; 80(2):194-202. PubMed ID: 33004330
[TBL] [Abstract][Full Text] [Related]
11. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
12. The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling.
Elfishawi SM; Mossallam GI; El-Fattah RA; El-Haddad A; Kamel AM
Hum Immunol; 2017 Nov; 78(11-12):684-691. PubMed ID: 28993188
[TBL] [Abstract][Full Text] [Related]
13. Role of HLA in congenital heart block: susceptibility alleles in mothers.
Sirén MK; Julkunen H; Kaaja R; Kurki P; Koskimies S
Lupus; 1999; 8(1):52-9. PubMed ID: 10025599
[TBL] [Abstract][Full Text] [Related]
14. Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block.
Clancy RM; Zheng P; O'Mahony M; Izmirly P; Zavadil J; Gardner L; Buyon JP
Arthritis Rheum; 2007 Dec; 56(12):4120-31. PubMed ID: 18050204
[TBL] [Abstract][Full Text] [Related]
15. KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.
Di Bona D; Aiello A; Colomba C; Bilancia M; Accardi G; Rubino R; Giannitrapani L; Tuttolomondo A; Cascio A; Caiaffa MF; Rizzo S; Di Lorenzo G; Candore G; Duro G; Macchia L; Montalto G; Caruso C;
J Viral Hepat; 2017 Sep; 24(9):768-775. PubMed ID: 28211154
[TBL] [Abstract][Full Text] [Related]
16. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
[TBL] [Abstract][Full Text] [Related]
17. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.
Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y
Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
[TBL] [Abstract][Full Text] [Related]
19. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T
Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799
[TBL] [Abstract][Full Text] [Related]
20. Passively acquired anti-SSA/Ro antibodies are required for congenital heart block following ovodonation but maternal genes are not.
Brucato A; Ramoni V; Penco S; Sala E; Buyon J; Clancy R
Arthritis Rheum; 2010 Oct; 62(10):3119-21. PubMed ID: 20499382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
